Key opportunities include rising demand for biologics characterization, driven by advancements in drug development and monoclonal antibody therapiesDublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Mass ...

Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...